MYDA Advisors’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-9,109
Closed -$354K 120
2018
Q2
$354K Buy
+9,109
New +$354K 0.15% 70